Treatment News : Scientists Hope to Repeat Functional Cure of ‘Mississippi Baby’

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » July 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


July 8, 2013

Scientists Hope to Repeat Functional Cure of ‘Mississippi Baby’

Following the apparent functional cure of a baby born to an HIV-positive mother in Mississippi, scientists have designed a long-term global trial in an attempt to repeat that success, reports. Investigators participating in the trial, which is sponsored by the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group, announced their trial design at a symposium on HIV cure research at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) in Kuala Lumpur.

Conducted in IMPAACT’s 71 sites around the world, the study will screen hundreds of infants in an attempt to find about 20 to 30 babies infected with HIV by mothers who, like the woman in the Mississippi case, were not treated for the virus during their pregnancies, or whose virus was not well controlled during the baby’s gestation. All of the babies will be treated with a three-drug antiretroviral (ARV) cocktail within 48 hours of birth, similar to the intensified treatment regimen given to the functionally cured baby. Following the week required to accurately test for HIV in the infants, those who test positive will receive a fourth ARV.

After about three years on therapy, the children will undergo screening to see whether there is evidence of HIV antibodies in their blood and whether their immune systems are producing the antibodies. In children who test negative for both screens, treatment will then be stopped in the hope that they will not experience viral rebound.

To read the Nature story, click here.

Search: Mississippi baby, functional cure, International Maternal Pediatric Adolescent AIDS Clinical Trials, IMPAACT, 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, IAS 2013.

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (0 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.